236 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (144)
- Autoimmune Disorders (3)
- Blood Disorders (6)
- Cancer (79)
- Diabetes (1)
- Gastrointestinal and Digestive Diseases (2)
- Healthy Volunteers (4)
- Heart Disease (2)
- Infectious Disease (4)
- Neurological Disorders (14)
- Nutrition (1)
- Obstetrics & Gynecology (1)
- Pediatrics (14)
- Psychiatric Disorders (1)
- Transplant (11)
- Urology (1)
Displaying 1 - 1 of 1
Condition: Skin Cancer / Melanoma
Investigator: Larisa Geskin, MD
Status: Closed
The purpose of this study is to determine how effective and safe the immune drug Nivolumab is for patients who have newly diagnosed cutaneous melanoma. Nivolumab is an anti-body, a type of human protein, that is being tested to see if it will allow the body's immune system to work against tumor cell…